- Home
- ITRG vs AGMB Comparison
ITRG vs AGMB Comparison
Compare ITRG & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | AGMB |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | Canada | Belgium |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 557.9M | 576.2M |
| IPO Year | 2017 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ITRG | AGMB |
|---|---|---|
| Price | $2.43 | $8.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $6.13 | ★ $37.67 |
| AVG Volume (30 Days) | ★ 1.4M | 139.5K |
| Earning Date | 11-05-2026 | 11-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.41 | N/A |
| Revenue Next Year | $24.58 | N/A |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.99 | $7.97 |
| 52 Week High | $4.87 | $17.82 |
Technical Indicators
Market Signals| Indicator | ITRG | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 31.21 |
| Support Level | $2.38 | N/A |
| Resistance Level | $2.96 | $12.53 |
| Average True Range (ATR) | 0.11 | 0.81 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 35.11 | 13.95 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.